HCWB — HCW Biologics Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1828673 ·
Last close
$4.55
Market Cap
$7.27M
52W High
$23.94
52W Low
$1.80
ADV30
186,617
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 6,543,001 | 6,531,930 | 3,250,122 | 3,472,480 | 27,342,213 | 1,228,879 | 21,579,779 |
| Dec 2025 | 27,010 | 5,401 | -2,947,409 | 719,232 | 24,520,013 | 1,952,464 | 21,755,244 |
| Sep 2025 | 15,606 | 3,121 | -3,276,624 | -4,554,336 | 25,445,540 | 1,096,909 | 27,552,737 |
| Jun 2025 | 6,550 | 1,310 | -3,361,829 | -1,927,730 | 28,909,636 | 2,438,962 | 28,961,608 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,452,987
Investing CF
$0
Financing CF
$11,574,253
CapEx
$-150,475
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.57
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-105,043,366
Inventory
—
Receivables
$74,844
ST Investments
—
EBIT TTM
$-1,136,406
Pretax Income TTM
$-1,960,168
Interest Exp TTM
$823,762
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,592,168
EBITDA
$-5,696,189
Free Cash Flow
$-10,438,363
Enterprise Value
$10,561,635
Total Cash
$1,228,879
Total Debt
$6,577,194
Shares Out
1,596,849
Trailing EPS
$-49.74
Book Value
$5.13
ROE
—
ROA
-15.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 54,232 | -11,257,288 | -7,959,709 | 24,520,013 | 21,755,244 | — | -13,391,617 |
| Dec 2024 | 2,566,792 | -27,629,216 | -30,023,814 | 30,236,578 | 37,006,750 | — | -14,227,428 |
| Dec 2023 | 2,841,794 | -25,717,160 | -24,994,277 | 28,513,660 | 15,051,943 | — | -22,514,121 |
| Dec 2022 | 6,722,090 | -15,078,778 | -14,900,703 | 46,809,155 | 9,380,649 | — | -10,386,110 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.55
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BOLT | Bolt Biotherapeutics, Inc. | $7.26M | $3.78 | — |
| XTLB | XTL BIOPHARMACEUTICALS LTD | $7.15M | $2.91 | — |
| NXTC | NextCure, Inc. | $7.12M | $1.97 | — |
| AVCRF | Avricore Health Inc. | $7.08M | $0.06 | — |
| ERNA | Ernexa Therapeutics Inc. | $7.07M | $6.06 | — |
News headlines (Yahoo Finance, 1h cache)
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
2026-06-30 12:25 · Yahoo
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
2026-06-26 12:55 · Yahoo
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
2026-06-16 11:00 · Yahoo
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
2026-05-27 11:45 · Yahoo
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
2026-05-22 20:02 · Yahoo
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
2026-05-21 13:53 · Yahoo
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
2026-05-18 14:35 · Yahoo
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
2026-05-14 20:25 · Yahoo
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies
2026-05-14 11:30 · Yahoo
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
2026-04-30 20:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.